$29.08 0.3%
BAX Stock Price vs. AI Score
Data gathered: December 26

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Baxter International (BAX)

Analysis generated December 6, 2024. Powered by Chat GPT.

Baxter International Inc. (NYSE: BAX) is a leading global medical products company specializing in critical care, nutrition, renal, hospital, and surgical products. The company operates in a highly competitive sector and is known for its contributions to healthcare innovations. With a diversified portfolio, global reach, and historical significance within the medical products industry, Baxter seeks to deliver high-quality care solutions that enhance patient outcomes.

Read full AI stock Analysis

Stock Alerts - Baxter International (BAX)

company logo Baxter International | December 10
Job postings are down by 16.2% in the last couple of days.
company logo Baxter International | December 10
Business Outlook among employees is down by 3.5% over the last month.
company logo Baxter International | December 7
AI Score is down by 23.5% in the last couple of days.
company logo Baxter International | December 5
Job postings are down by 16.8% in the last couple of days.

About Baxter International

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.


Baxter International
Price $29.08
Target Price Sign up
Volume 1,580,000
Market Cap $14.8B
Year Range $28.9 - $40.16
Dividend Yield 2.31%
PE Ratio 116.32
Analyst Rating 20% buy
Industry Medical & Dental Instruments

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '242.8B2.59B1.03B140M314M0.800
Q2 '243.84B4.01B1.43B-314M11M0.680
Q1 '243.65B3.45B1.39B37M383M0.650
Q4 '233.89B4.21B1.47B245M1.32B0.880
Q3 '233.69B4.09B1.06B2.51B2.58B0.680

Insider Transactions View All

Mason Jeanne K filed to sell 142,290 shares at $40.6.
March 5 '24
STROUCKEN ALBERT P L filed to sell 36,835 shares at $37.5.
March 22 '23
Kunzler Jacqueline filed to sell 16,725 shares at $40.5.
February 23 '23
Mason Jeanne K filed to sell 126,231 shares at $44.7.
January 19 '23
HELLMAN PETER S filed to sell 27,629 shares at $76.6.
April 7 '22

Congress Trading View All

Politician Filing Date Type Size
Debbie Wasserman Schultz
Nov 21, 24 Buy $1K - $15K
Earl Blumenauer
Aug 6, 24 Buy $15K - $50K
Rohit Khanna
Democrat
Jun 5, 24 Buy $1K - $15K

What is the Market Cap of Baxter International?

The Market Cap of Baxter International is $14.8B.

What is Baxter International's PE Ratio?

As of today, Baxter International's PE (Price to Earnings) ratio is 116.32.

What is the current stock price of Baxter International?

Currently, the price of one share of Baxter International stock is $29.08.

How can I analyze the BAX stock price chart for investment decisions?

The BAX stock price chart above provides a comprehensive visual representation of Baxter International's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Baxter International shares. Our platform offers an up-to-date BAX stock price chart, along with technical data analysis and alternative data insights.

Does BAX offer dividends to its shareholders?

Yes, Baxter International (BAX) offers dividends to its shareholders, with a dividend yield of 2.31%. This dividend yield represents Baxter International's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Baxter International in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Baxter International?

Some of the similar stocks of Baxter International are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.